Open Access
Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis
Publication type: Journal Article
Publication date: 2022-05-26
scimago Q2
wos Q1
SJR: 0.668
CiteScore: 4.2
Impact factor: 2.5
ISSN: 22118020, 22118039
PubMed ID:
35836973
General Biochemistry, Genetics and Molecular Biology
General Medicine
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Aging
3 publications, 17.65%
|
|
|
Environmental Toxicology
2 publications, 11.76%
|
|
|
Biomolecules
1 publication, 5.88%
|
|
|
Frontiers in Endocrinology
1 publication, 5.88%
|
|
|
Nutrients
1 publication, 5.88%
|
|
|
Biomedical Journal
1 publication, 5.88%
|
|
|
Pharmaceutics
1 publication, 5.88%
|
|
|
Nanomedicine: Nanotechnology, Biology, and Medicine
1 publication, 5.88%
|
|
|
BMC Complementary Medicine and Therapies
1 publication, 5.88%
|
|
|
International Immunopharmacology
1 publication, 5.88%
|
|
|
International Journal of Molecular Sciences
1 publication, 5.88%
|
|
|
International Journal of Cancer
1 publication, 5.88%
|
|
|
World Journal of Gastrointestinal Oncology
1 publication, 5.88%
|
|
|
Oncology Reports
1 publication, 5.88%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
|
|
|
MDPI
4 publications, 23.53%
|
|
|
Impact Journals
3 publications, 17.65%
|
|
|
Elsevier
3 publications, 17.65%
|
|
|
Wiley
3 publications, 17.65%
|
|
|
Frontiers Media S.A.
1 publication, 5.88%
|
|
|
Springer Nature
1 publication, 5.88%
|
|
|
Baishideng Publishing Group
1 publication, 5.88%
|
|
|
Spandidos Publications
1 publication, 5.88%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
17
Total citations:
17
Citations from 2024:
12
(70.58%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Liyis B. G., Nolan J., Maharjana M. A. Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis // BioMedicine (Netherlands). 2022. Vol. 12. No. 2. pp. 1-9.
GOST all authors (up to 50)
Copy
Liyis B. G., Nolan J., Maharjana M. A. Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis // BioMedicine (Netherlands). 2022. Vol. 12. No. 2. pp. 1-9.
Cite this
RIS
Copy
TY - JOUR
DO - 10.37796/2211-8039.1308
UR - https://doi.org/10.37796/2211-8039.1308
TI - Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis
T2 - BioMedicine (Netherlands)
AU - Liyis, B G
AU - Nolan, J
AU - Maharjana, M A
PY - 2022
DA - 2022/05/26
PB - Elsevier
SP - 1-9
IS - 2
VL - 12
PMID - 35836973
SN - 2211-8020
SN - 2211-8039
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Liyis,
author = {B G Liyis and J Nolan and M A Maharjana},
title = {Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis},
journal = {BioMedicine (Netherlands)},
year = {2022},
volume = {12},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.37796/2211-8039.1308},
number = {2},
pages = {1--9},
doi = {10.37796/2211-8039.1308}
}
Cite this
MLA
Copy
Liyis, B. G., et al. “Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis.” BioMedicine (Netherlands), vol. 12, no. 2, May. 2022, pp. 1-9. https://doi.org/10.37796/2211-8039.1308.